Join Lonza's experts during a scientific program presentation and schedule a meeting to discuss your next project at our virtual booth. 

In an industry as dynamic as the life science and healthcare sector, The Life Science Executive (LSX) World Congress brings the people together who are tackling the biggest challenges in the industry today. Join the founders and CEOs of innovative start-ups through to publicly listed life sciences giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
 
 
We hope you can join us for the following virtual presentation. Mark your calendar!
  
 

Program presentation

130x160-DavidLyon.jpg

Avoiding CMC failures through phase-appropriate clinical development and supply chain setup  

Thursday, February 4, 2021. 14:00 pm - 15:00 pm (GMT/UTC)
 
Rhony Aufdenblatten, PhD., Head of Commercial Development
 
About the presentation:
Today’s clinical pipelines are at record levels and driven by innovation in approach e.g. use of AI in discovery and ongoing investment in new and more patient-centric therapies. More and more of these programs follow accelerated development and approval pathways. As a result, target timelines for the start of clinical trials are getting shorter and shorter. In this already complex environment, Chemical and Manufacturing Controls should not be the cause for increased risk or delays.

This presentation will cover phase-appropriate development approaches and supply chain solutions for integrated drug substance and drug product projects that can accelerate program timelines and reduce overall complexity and risk.

  
 

Meet 1-2-1 with our expert in the virtual event: schedule a session.

 

 
Can’t attend the virtual event? Access other relevant technical content in our Knowledge Center:
  • On-demand webinar "Lonza small molecule capabilities: drug substance to drug product, parenteral to oral", watch now
  • On-demand webinar "Navigating CMC Regulatory requirements for accelerated commercialization", watch now
  • Whitepaper/executive summary "Solid form screening: a key drug development step", read now
  • 2020 AAPS PharmSci 360 presented posters and rapid-fires, see now
   



  
 

Lorem ipsum dolor sit amet